VENLO, Netherlands--(BUSINESS WIRE)--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a significant increase in the powerful capabilities of its QIAcuity Digital PCR (dPCR) system ...
Qiagen, a Netherlands-based leading global provider of Sample to Insight solutions, announced a significant increase in the powerful capabilities of its QIAcuity Digital PCR (dPCR) system with a more ...
The adoption of QIAcuity digital PCR research instrument is strong, with more than 2,700 cumulative placements at the end of 2024 and citations in over 550 publications. Key customers include ...
According to Ben Hindson, Ph.D., the paper's first author and a Bio-Rad Laboratories, Inc. chemist, ddPCR overcomes the high costs, limited throughput, and complicated workflows that hampered adoption ...
Certains résultats ont été masqués, car ils peuvent vous être inaccessibles.
Afficher les résultats inaccessibles